Intracervical fibrin sealants: a potential treatment for early preterm premature rupture of the membranes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11228489.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report our experience with a transvaginally applied intracervical fibrin sealant at <24 weeks' gestation. This is an observational study of a referred patient population, with preterm premature rupture of the membranes at <24 weeks' gestation. Twelve women consented to our protocol. The mean gestational age at preterm premature rupture of membranes was 19 weeks 4 days (range, 13-23 weeks); the mean gestational age at treatment was 20 weeks 5 days (range, 17-23 weeks). All women had a diminution in the amount of amniotic fluid leakage with an increase in amniotic fluid index. Among the 12 pregnancies (13 fetuses), there were 7 surviving neonates. Two women had apparent "resealing" of the membranes. Fibrin sealants in midtrimester rupture of the membranes may lead to improved outcomes and now warrant formal evaluation.
Medical subject headings
- Premature Rupture of Fetal Membranes
- Fibrin Tissue Adhesive